Date: May 21, 2026 Source: Anglia Ruskin University Summary: A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term
J Clin Invest (1988) 81(6):167581.10.1172/JCI113505 106 CheungGWKokorovicALamCKChariMLamTK
Data GLP-1 for Adults Q1 2026 Quarterly rates per 100,000 of patients receiving clinical care being prescribed, dispensed, or reporting that they started a GLP-1 medication
Efficacy and safety of stem cell therapy for acute and subacute ischemic stroke: a systematic review and meta-analysis
This protocol consists of infusing half the 36 mM NAC dose over a 1-hour period starting at 2 hours after the APAP dose, followed by 1/6 of the dose over the next 4-hour period and then 1/3 of the dose over an additional 16 hours
Who can access each medication also differs